GLP-1 Lab Monitoring: Bloodwork for Ozempic, Wegovy, Mounjaro & Zepbound

GLP-1 receptor agonists are effective precisely because they act broadly — they slow gastric emptying, improve insulin sensitivity, and suppress appetite. Those same broad actions are why bloodwork matters:

• Liver: semaglutide and tirzepatide can transiently raise liver enzymes in roughly 5% of patients. Usually benign and often part of the fatty-liver improvement that comes with weight loss — but you want to see the trend, not guess.
• Kidneys: the nausea and vomiting some people get, especially during dose escalation, can cause dehydration that stresses the kidneys. A CMP catches a rising creatinine early.
• Nutrition: eating substantially less means absorbing substantially fewer micronutrients. B12, iron (via ferritin), and vitamin D drop first — and their symptoms (fatigue, brain fog, hair shedding) get blamed on the drug when they're actually a fixable deficiency.

None of this means GLP-1s are unsafe — they're FDA-approved and well studied. It means the therapy has measurable effects worth measuring, which is exactly what standard-of-care monitoring is for.

The GLP-1 Monitoring & Weight Management panel is built around the questions a clinician asks at each visit:

• Is it safe? — CMP (liver + kidney), TSH (rare thyroid effects), CBC with differential.
• Is it working? — A1c (3-month glucose average — see A1c levels explained for how to read yours), fasting insulin (insulin-resistance tracking), lipid panel (should improve with weight loss).
• What's the diet costing me? — B12, ferritin, vitamin D, and hs-CRP (the inflammation that should fall as you lose weight).

Ordering these ten separately runs about $270; the panel is $169.99. A walk-in hospital lab would typically bill $700-1000 for the equivalent without insurance.

Baseline before your first dose is the highest-value draw — it's the "before" that makes every later result interpretable, and it catches any pre-existing liver, kidney, or thyroid issue before the drug is in the picture.

Then every 3 months while you're on therapy, which matches how most prescribers schedule follow-ups. If you're escalating dose or having significant GI side effects, an earlier check is reasonable.

Timing: fast 9-12 hours (water is fine) for accurate glucose, insulin, lipids, and CMP. For weekly injections, draw at a consistent point in your weekly cycle — often 3-4 days after your shot — so your trend isn't muddied by where you are in the dosing week.

GLP-1s reach people through several routes now: a prescription from a doctor or telehealth service, compounded semaglutide/tirzepatide from a compounding pharmacy, or research-chemical sources. We take no position on which route you're using — but the physiology is identical, and so is the bloodwork that keeps it safe.

If anything, the less medical oversight your source comes with, the more valuable independent monitoring becomes — a prescriber orders these labs for you; if no one is, ordering them yourself is how you don't fly blind. TestWell's panel is physician-reviewed and results land with a plain-language summary, so an abnormal value is a clear prompt to loop in a clinician.